Arrowhead Pharmaceuticals, Inc. · NASDAQ:ARWR

Avoro Capital Advisors LLC reported a 8.30% stake in Arrowhead Pharmaceuticals, Inc. (Schedule 13G/A)

Event Jun 30, 2025 · Filed Aug 14, 2025

Avoro Capital Advisors LLC reported a 8.30% stake in Arrowhead Pharmaceuticals, Inc., 11,517,441 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).

Stake
8.30%
Shares
11,517,441
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Avoro Capital Advisors LLC8.30%11,517,441
Behzad Aghazadeh8.30%11,517,441

Source

View original at SEC

Related